Vibha Taneja Thomas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Vibha Taneja Thomas has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Kartik Konduri
Section of Thoracic Oncology, Baylor Sammons Cancer Center, Baylor University Medical Center, Dallas, TX, USA
1 shared publicationMohan Penmetcha
Department of Rheumatology, Texas Health Presbyterian Hospital, Plano, TX, USA
1 shared publicationRobert Mennel
1 shared publicationRobin Dobson
1 shared publicationStacy Hinson
Department of Pathology, Baylor University Medical Center, Dallas, TX, USA
1 shared publication
Latest Publications
- Open Access
- 1 December 2021
- Published by Elmer Press, Inc. in Journal of Hematology
- Vol. 10 (6) , 274-276
Myelodysplastic Syndrome Associated With Auto-Immune Inflammatory Disease in VEXAS Syndrome
- 1 December 2021
- Published by Elmer Press, Inc. in Journal of Hematology
- Vol. 10 (6) , 274-276
Open AccessMyelodysplastic Syndrome Associated With Auto-Immune Inflammatory Disease in VEXAS Syndrome
- 1 October 2011
- Published by Taylor & Francis in Baylor University Medical Center Proceedings
- Vol. 24 (4) , 350-352
Primary Cutaneous Large B-Cell Lymphoma, Leg Type
Primary cutaneous large B-cell lymphoma, leg type, is a rare and aggressive neoplasm as defined by the recently updated World Health Organization–European Organization for Research and Treatment of Cancer classification of cutaneous lymphomas. We present a case of a 74-year-old woman who presented with a cutaneous lesion on her forearm. Skin biopsy revealed pathology consistent with this entity. The patient was treated with systemic chemotherapy with rituximab combined with doxorubicin, cyclophosphamide, vincristine, and prednisone. Here, we review the available literature and summarize clinical features and management of this uncommon subtype of non-Hodgkin lymphoma.
- 1 October 2011
- Published by Taylor & Francis in Baylor University Medical Center Proceedings
- Vol. 24 (4) , 350-352
Primary Cutaneous Large B-Cell Lymphoma, Leg Type
Primary cutaneous large B-cell lymphoma, leg type, is a rare and aggressive neoplasm as defined by the recently updated World Health Organization–European Organization for Research and Treatment of Cancer classification of cutaneous lymphomas. We present a case of a 74-year-old woman who presented with a cutaneous lesion on her forearm. Skin biopsy revealed pathology consistent with this entity. The patient was treated with systemic chemotherapy with rituximab combined with doxorubicin, cyclophosphamide, vincristine, and prednisone. Here, we review the available literature and summarize clinical features and management of this uncommon subtype of non-Hodgkin lymphoma.
- 14 September 2011
- Published by SAGE Publications in Therapeutic Advances in Medical Oncology
- Vol. 4 (1) , 31-37
Epithelial–mesenchymal transition in pulmonary carcinosarcoma: case report and literature review
Pulmonary carcinosarcoma is a rare and aggressive neoplasm that has both epithelial and mesenchymal components. We report on a 63-year-old woman who was found to have a right upper-lobe pulmonary carcinosarcoma with metastases to the liver and gastric fundus. There are currently no published guidelines on the treatment of pulmonary sarcomatoid carcinomas. However, with our expanding knowledge of cancer metastasis, cases of carcinosarcoma illustrate our current understanding of epithelial–mesenchymal transition in action. Here, we discuss the development and treatment of these biphasic tumors and the possible role of epithelial–mesenchymal transition.
- 14 September 2011
- Published by SAGE Publications in Therapeutic Advances in Medical Oncology
- Vol. 4 (1) , 31-37
Epithelial–mesenchymal transition in pulmonary carcinosarcoma: case report and literature review
Pulmonary carcinosarcoma is a rare and aggressive neoplasm that has both epithelial and mesenchymal components. We report on a 63-year-old woman who was found to have a right upper-lobe pulmonary carcinosarcoma with metastases to the liver and gastric fundus. There are currently no published guidelines on the treatment of pulmonary sarcomatoid carcinomas. However, with our expanding knowledge of cancer metastasis, cases of carcinosarcoma illustrate our current understanding of epithelial–mesenchymal transition in action. Here, we discuss the development and treatment of these biphasic tumors and the possible role of epithelial–mesenchymal transition.